Nano Pharmaceuticals
Market Cap
₹200 ₹200 Cr.
P/E
10.42
PEG = P/E ÷ 5yr forward EPS CAGR

The forward EPS CAGR is estimated individually for each company - factoring in its guidance, industry, and growth drivers - not generic rule-based projection.

Key Ratios

Debt to Equity
Debt to Equity
0.02
Div Yield (%)
Div Yield (%)
0.36
Individual < 2 lac
Individual < 2 lac
16.65 %
Institutions
Institutions
-
Market cap
Market cap
200 Cr
No. of Shareholders
No. of Shareholders
3,913
OPM (%)
OPM (%)
19.15 %
PE
PE
10.42
Prom Holding
Prom Holding
71.51 %
ROCE (%)
ROCE (%)
16.30
ROE (%)
ROE (%)
12.01
Sales
Sales
96.70 Cr
  • Coral Laboratories
  • Brooks Laboratories
  • Medico Remedies
  • TJI Pharma - Small Cap
Last updated on 25 Sep 2026
  • Coral Laboratories makes pharmaceutical formulations at its plants in Daman and Dehradun. It is a single-segment formulations business with no subsidiaries.
  • It sells mainly abroad, with Rest of World about 69% of FY26 product sales, Ethiopia about 19% and India about 11%.
  • Profit comes from export formulations, with treasury income supporting profit. Unhedged exports mean a 5% currency move shifts PBT by about Rs1.26Cr.
  • The ointment plant at Dehradun added 360,000 kgs to 180,000 kgs that ran at about 80%. Management wants to grow exports.
  • After weak FY26 sales fell about 25%, Q1FY27 revenue rose to Rs29.62Cr. Near-term profit depends on whether this rebound holds.
  • It holds large fixed deposits against a small overdraft. Inventories doubled in FY26 while sales fell.
  • Some export receivables are long overdue, with part outstanding for over three years.
  • Second quarter with expanded ointment capacity ~mid-Nov 2026
    It reveals sales volumes from the expanded capacity and inventory unwind from Rs20.53Cr.
Price Range

See where the stock is trading versus its 52-week high and low.

Low
360
52W Range
High
679
Timeline

Key company specific updates.

Custom financial statement

Edit rows

Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

Corporate Actions

Consolidated
DATE
DETAILS
Show More
Show Less
Show More
Show Less

FAQs on Coral Laboratories Ltd. Business

Coral Laboratories Ltd operates in the pharmaceutical industry with a strong focus on quality control. They offer a wide range of products including capsules, tablets, liquids, ointments, injections, and more.

Coral Laboratories major competitors are Vaidya Sane Ayur Lab, Medico Remedies, Brooks Laboratories, Gennex Laboratories, Krebs Biochem.&Inds, Kimia Biosciences, Achyut Healthcare.
Market Cap of Coral Laboratories is ₹196 Crs.
While the median market cap of its peers are ₹163 Crs.

Coral Laboratories seems to be financially stable compared to its competitors.
The probability of it going bankrupt or facing a financial crunch seem to be lower than its immediate competitors.

Company Filing

2026 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010
Annual Report FY26 FY25 FY24 FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12 FY11 FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary

Discussions & Analysis

Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material